CA2153730A1 - Activite immunostimulatrice d'un oligosaccharide de serotype 8 de streptococcus pneumoniae - Google Patents

Activite immunostimulatrice d'un oligosaccharide de serotype 8 de streptococcus pneumoniae

Info

Publication number
CA2153730A1
CA2153730A1 CA002153730A CA2153730A CA2153730A1 CA 2153730 A1 CA2153730 A1 CA 2153730A1 CA 002153730 A CA002153730 A CA 002153730A CA 2153730 A CA2153730 A CA 2153730A CA 2153730 A1 CA2153730 A1 CA 2153730A1
Authority
CA
Canada
Prior art keywords
oligosaccharide
oligosaccharides
polysaccharide
conjugate
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002153730A
Other languages
English (en)
Inventor
Andrew J. Malcolm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Alberta Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alberta Research Council filed Critical Alberta Research Council
Priority to CA002153730A priority Critical patent/CA2153730A1/fr
Priority to JP9500049A priority patent/JPH11506110A/ja
Priority to KR1019970707283A priority patent/KR19990007777A/ko
Priority to CZ973278A priority patent/CZ327897A3/cs
Priority to IL12158596A priority patent/IL121585A0/xx
Priority to NZ309713A priority patent/NZ309713A/xx
Priority to NZ337730A priority patent/NZ337730A/xx
Priority to AU59944/96A priority patent/AU725279B2/en
Priority to EP96917311A priority patent/EP0831894A1/fr
Priority to PCT/CA1996/000387 priority patent/WO1996040225A1/fr
Publication of CA2153730A1 publication Critical patent/CA2153730A1/fr
Priority to NO974727A priority patent/NO974727L/no
Priority to MX9707944A priority patent/MX9707944A/es
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002153730A 1995-06-07 1995-07-12 Activite immunostimulatrice d'un oligosaccharide de serotype 8 de streptococcus pneumoniae Abandoned CA2153730A1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
CA002153730A CA2153730A1 (fr) 1995-07-12 1995-07-12 Activite immunostimulatrice d'un oligosaccharide de serotype 8 de streptococcus pneumoniae
NZ309713A NZ309713A (en) 1995-06-07 1996-06-06 Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
KR1019970707283A KR19990007777A (ko) 1995-06-07 1996-06-06 면역성 및 면역자극성 올리고당 조성물 및 이를 제조하고 이용하는 방법
CZ973278A CZ327897A3 (cs) 1995-06-07 1996-06-06 Imunogenní a imunostimulační oligosacharidové kompozice, způsoby jejich přípravy a použití
IL12158596A IL121585A0 (en) 1995-06-07 1996-06-06 Immunogenic and immunostimulatory oligosaccharide compositions and methods of preparing and using them
JP9500049A JPH11506110A (ja) 1995-06-07 1996-06-06 免疫原性および免疫刺激性オリゴサッカライド組成物ならびにそれらの作製法および使用法
NZ337730A NZ337730A (en) 1995-06-07 1996-06-06 use of an oligosaccharide hapten- carrier conjugate for immunizing against a bacterial or viral pathogen by administering
AU59944/96A AU725279B2 (en) 1995-06-07 1996-06-06 Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them
EP96917311A EP0831894A1 (fr) 1995-06-07 1996-06-06 Compositions oligasaccharidiques immunogenes et immunostimulatrices et leurs procedes de production et d'utilisations
PCT/CA1996/000387 WO1996040225A1 (fr) 1995-06-07 1996-06-06 Compositions oligasaccharidiques immunogenes et immunostimulatrices et leurs procedes de production et d'utilisations
NO974727A NO974727L (no) 1995-06-07 1997-10-13 Immunogene og immunostimulatoriske oligosakkarid sammensetninger og fremgangsmåter for fremstilling derav
MX9707944A MX9707944A (es) 1995-06-07 1997-10-15 Composiciones de oligosacaridos inmunigenicos e inmunoestimulatorios y metodos para fabricarlos y utilizarlos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002153730A CA2153730A1 (fr) 1995-07-12 1995-07-12 Activite immunostimulatrice d'un oligosaccharide de serotype 8 de streptococcus pneumoniae

Publications (1)

Publication Number Publication Date
CA2153730A1 true CA2153730A1 (fr) 1997-01-13

Family

ID=4156210

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002153730A Abandoned CA2153730A1 (fr) 1995-06-07 1995-07-12 Activite immunostimulatrice d'un oligosaccharide de serotype 8 de streptococcus pneumoniae

Country Status (1)

Country Link
CA (1) CA2153730A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123417B2 (en) 2018-02-05 2021-09-21 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11147864B2 (en) 2018-02-05 2021-10-19 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11224652B2 (en) 2016-08-05 2022-01-18 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11241489B2 (en) 2016-08-05 2022-02-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11951162B2 (en) 2018-04-18 2024-04-09 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11224652B2 (en) 2016-08-05 2022-01-18 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11241489B2 (en) 2016-08-05 2022-02-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11123417B2 (en) 2018-02-05 2021-09-21 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11147864B2 (en) 2018-02-05 2021-10-19 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11911452B2 (en) 2018-02-05 2024-02-27 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US11951162B2 (en) 2018-04-18 2024-04-09 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof

Similar Documents

Publication Publication Date Title
US6132723A (en) Immunogenic oligosaccharide compositions
AU725279B2 (en) Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them
US5916571A (en) Immunostimulating activity of streptococcus pneumoniae serotype 8 oligosaccharides
KR102225282B1 (ko) 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
EP3096786B1 (fr) Polysaccharides capsulaires de streptococcus pneumoniae et leurs conjugués
TWI748810B (zh) 包含結合之莢膜醣抗原的免疫原組合物及其用途
KR101538535B1 (ko) 15가 폐렴구균성 폴리사카라이드-단백질 접합체 백신 조성물
KR101730749B1 (ko) 다가 폐렴구균 다당류-단백질 접합체 조성물
EP2170391B1 (fr) Polysaccharides modifiés pour vaccins conjugués
HU228384B1 (en) Vaccine compositions
KR20150129052A (ko) 다가 폐렴구균 다당류-단백질 접합체 조성물
WO2019175145A1 (fr) Vaccins contre des infections des voies urinaires
CA2153733A1 (fr) Compositions immunogenes a base d'oligosaccharides
CA2153730A1 (fr) Activite immunostimulatrice d'un oligosaccharide de serotype 8 de streptococcus pneumoniae
US5952454A (en) Linking compounds useful for coupling carbohydrates to amine-containing carriers
Malcolm et al. Surface layers from Bacillus alvei as a carrier for a Streptococcus pneumoniae conjugate vaccine
JP2016525507A (ja) 緑膿菌ワクチンのための合成オリゴ糖
US20110236414A1 (en) Bacterial Polysaccharide-Polypeptide Conjugate Compositions
CN101130071B (zh) 疫苗
Robbins Prevention of Invasive Bacterial Diseases by Immunization with Polysaccharide-Protein Conjugates JB Robbins, R. Schneerson, SC Szu, A. Fattom, Y. Yang, T. Lagergard, C. Chu, and US Sørensen Laboratory of Development and Molecular Immunity, National Institute of Child

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20070712